Validation of Temporal Optimization Effects for a Single Fraction of Radiation In Vitro

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1240-1246

  Altman, Michael B ^a   Stinauer, Michelle A ^b   Javier, Desler ^b   Smith, Brett D ^b   Herman, Lauren C ^a   Pytynia, Matthew L ^a   Aydogan, Bulent ^a,b   Pelizzari, Charles A ^a   Chmura, Steven J ^a   Roeske, John C ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypofractionation; IMRT; In vitro experiments; Linear quadratic model; Temporal optimization

Indexed keywords

B CELLS; CELL LINES; CELL SURVIVAL; CLONOGENIC ASSAYS; HYPOFRACTIONATION; IN VITRO EXPERIMENTS; IN-CELL; IN-VITRO; LINEAR-QUADRATIC MODELS; MODELING STUDIES; OPTIMIZATION EFFECTS; RADIATION THERAPY; SHAPED PATTERN; TEMPORAL PATTERN; TREATMENT PLANNING; TRIANGLE PATTERN; WELL PLATES;

CELL CULTURE; CHEMICAL MODIFICATION; OPTIMIZATION; PHYSICAL THERAPY; RADIATION EFFECTS;

EXPERIMENTS;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CLONOGENIC ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTENSITY MODULATED RADIATION THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; VALIDATION STUDY; ADENOCARCINOMA; ALGORITHM; COLON TUMOR; DRUG SCREENING; HEAD AND NECK TUMOR; MALE; METHODOLOGY; PROSTATE TUMOR; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; TIME; TUMOR CELL LINE;

ADENOCARCINOMA; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE FRACTIONATION; HEAD AND NECK NEOPLASMS; HUMANS; LINEAR MODELS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; TIME FACTORS; TUMOR STEM CELL ASSAY;

EID: 70449711675     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.076     Document Type: Article

References (31)

1. Fowler J.F., Welsh J.S., and Howard S.P. Loss of biological effect in prolonged fraction delivery. Int J Radiat Oncol Biol Phys 59 (2004) 242-249
2. Wang J.Z., Li X.A., D'Souza W.D., et al. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys 57 (2003) 543-552
3. Murphy M.J., Lin P.S., and Ozhasoglu C. Intra-fraction dose delivery timing during stereotactic radiotherapy can influence the radiobiological effect. Med Phys 34 (2007) 481-484
4. Benedict S.H., Lin P.S., Zwicker R.D., et al. The biological effectiveness of intermittent irradiation as a function of overall treatment time: Development of correction factors for linac-based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 37 (1997) 765-769
5. Wang J.Z., and Li X.A. Impact of tumor repopulation on radiotherapy planning. Int J Radiat Oncol Biol Phys 61 (2005) 220-227
6. Welsh J.S., Howard S.P., and Fowler J.F. Dose rate in external beam radiotherapy for prostate cancer: An overlooked confounding variable?. Urology 62 (2003) 204-206
7. Bortfeld T., and Paganetti H. The biologic relevance of daily dose variations in adaptive treatment planning. Int J Radiat Oncol Biol Phys 65 (2006) 899-906
8. Moiseenko V., Duzenli C., and Durand R.E. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery. Med Phys 34 (2007) 1514-1520
9. Bewes J.M., Suchowerska N., Jackson M., et al. The radiobiological effect of intra-fraction dose-rate modulation in intensity modulated radiation therapy (IMRT). Phys Med Biol 53 (2008) 3567-3578
10. Zheng X.K., Chen L.H., Yan X., et al. Impact of prolonged fraction dose-delivery time modeling intensity-modulated radiation therapy on hepatocellular carcinoma cell killing. World J Gastroenterol 11 (2005) 1452-1456
11. Paganetti H. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy. Int J Radiat Oncol Biol Phys 63 (2005) 892-900
12. Sterzing F., Munter M.W., Schafer M., et al. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol 181 (2005) 42-48
13. Keall P.J., Chang M., Benedict S., et al. Investigating the temporal effects of respiratory-gated and intensity-modulated radiotherapy treatment delivery on in vitro survival: An experimental and theoretical study. Int J Radiat Oncol Biol Phys 71 (2008) 1547-1552
14. Kuperman VY, Ventura AM, Sommerfeldt M. Effect of radiation protraction in intensity-modulated radiation therapy with direct aperture optimization: A phantom study. Phys Med Biol;53:3279-3292.
15. Bonner W.M. Phenomena leading to cell survival values which deviate from linear-quadratic models. Mutat Res 568 (2004) 33-39
16. Carlson D.J., Stewart R.D., Li X.A., et al. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol 49 (2004) 4477-4491
17. Chmura S.J., Farrey K., Wang S., et al. Impact of prolonged treatment times. In: Roeske J.C., and Mundt A. (Eds). Intensity modulated radiation therapy: A clinical perspective (2005), Decker, New York 648
18. Altman M.B., Chmura S.J., Deasy J.O., et al. Optimization of the temporal pattern of radiation: An IMRT based study. Int J Radiat Oncol Biol Phys 66 (2006) 898-905
19. Lin P.S., and Wu A. Not all 2 Gray radiation prescriptions are equivalent: Cytotoxic effect depends on delivery sequences of partial fractionated doses. Int J Radiat Oncol Biol Phys 63 (2005) 536-544
20. Brenner D.J., and Hall E.J. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 20 (1991) 181-190
21. Lowry R. VassarStats: Statistical Computation Web Site; 2001. Available at: http://faculty.vassar.edu/lowry/VassarStats.html. Accessed March 7, 2009.
22. Amer A.M., Mott J., Mackay R.I., et al. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 56 (2003) 199-207
23. Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 56 (2003) 1093-1104
24. Koukourakis M.I., Touloupidis S., Manavis J., et al. Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: Rationale, technique and early experience. Anticancer Res 24 (2004) 3239-3243
25. Wang J.Z., Guerrero M., and Li X.A. How low is the alpha/beta ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 55 (2003) 194-203
26. Pawlicki T., Kim G.Y., Hsu A., et al. Investigation of linac-based image-guided hypofractionated prostate radiotherapy. Med Dosim 32 (2007) 71-79
27. Hossain S., Xia P., Chuang C., et al. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 35 (2008) 4041-4048
28. Macdermed D.M., Weichselbaum R.R., and Salama J.K. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 98 (2008) 202-206
29. Stewart R.D., and Li X.A. BGRT: Biologically guided radiation therapy-the future is fast approaching!. Med Phys 34 (2007) 3739-3751
30. Yang Y., and Xing L. Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 32 (2005) 1473-1484
31. Penagaricano J.A., Papanikolaou N., Wu C., et al. An assessment of biologically-based optimization (BORT) in the IMRT era. Med Dosim 30 (2005) 12-19